These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

717 related items for PubMed ID: 18701499

  • 1. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
    Gho JW, Ip WK, Chan KY, Law PT, Lai PB, Wong N.
    Cancer Res; 2008 Aug 15; 68(16):6743-51. PubMed ID: 18701499
    [Abstract] [Full Text] [Related]

  • 2. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
    Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Qiyong L, Fujii T, Sugimoto H, Takeda S, Nakao A.
    Ann Surg Oncol; 2010 Mar 15; 17(3):923-32. PubMed ID: 19898900
    [Abstract] [Full Text] [Related]

  • 3. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
    Lu CY, Hsieh SY, Lu YJ, Wu CS, Chen LC, Lo SJ, Wu CT, Chou MY, Huang TH, Chang YS.
    Genes Chromosomes Cancer; 2009 Dec 15; 48(12):1057-68. PubMed ID: 19760608
    [Abstract] [Full Text] [Related]

  • 4. Reduced CRYL1 expression in hepatocellular carcinoma confers cell growth advantages and correlates with adverse patient prognosis.
    Cheng IK, Ching AK, Chan TC, Chan AW, Wong CK, Choy KW, Kwan M, Lai PB, Wong N.
    J Pathol; 2010 Feb 15; 220(3):348-60. PubMed ID: 19927314
    [Abstract] [Full Text] [Related]

  • 5. Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma.
    Hellerbrand C, Mühlbauer M, Wallner S, Schuierer M, Behrmann I, Bataille F, Weiss T, Schölmerich J, Bosserhoff AK.
    Carcinogenesis; 2006 Jan 15; 27(1):64-72. PubMed ID: 16081515
    [Abstract] [Full Text] [Related]

  • 6. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
    Lim SO, Gu JM, Kim MS, Kim HS, Park YN, Park CK, Cho JW, Park YM, Jung G.
    Gastroenterology; 2008 Dec 15; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.
    Wong QW, Lung RW, Law PT, Lai PB, Chan KY, To KF, Wong N.
    Gastroenterology; 2008 Jul 15; 135(1):257-69. PubMed ID: 18555017
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma.
    Yeh SH, Wu DC, Tsai CY, Kuo TJ, Yu WC, Chang YS, Chen CL, Chang CF, Chen DS, Chen PJ.
    Clin Cancer Res; 2006 Feb 15; 12(4):1097-108. PubMed ID: 16489062
    [Abstract] [Full Text] [Related]

  • 14. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L, Xi-Ran Z.
    Hepatogastroenterology; 2004 Feb 15; 51(56):515-25. PubMed ID: 15086194
    [Abstract] [Full Text] [Related]

  • 15. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma.
    Iwata N, Yamamoto H, Sasaki S, Itoh F, Suzuki H, Kikuchi T, Kaneto H, Iku S, Ozeki I, Karino Y, Satoh T, Toyota J, Satoh M, Endo T, Imai K.
    Oncogene; 2000 Nov 02; 19(46):5298-302. PubMed ID: 11077447
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.
    Perugorria MJ, Castillo J, Latasa MU, Goñi S, Segura V, Sangro B, Prieto J, Avila MA, Berasain C.
    Cancer Res; 2009 Feb 15; 69(4):1358-67. PubMed ID: 19190340
    [Abstract] [Full Text] [Related]

  • 18. Abnormal expression of JUNB gene in hepatocellular carcinoma.
    Chang YS, Yeh KT, Yang MY, Liu TC, Lin SF, Chan WL, Chang JG.
    Oncol Rep; 2005 Mar 15; 13(3):433-8. PubMed ID: 15706412
    [Abstract] [Full Text] [Related]

  • 19. Identification of PEG10 as a progression related biomarker for hepatocellular carcinoma.
    Ip WK, Lai PB, Wong NL, Sy SM, Beheshti B, Squire JA, Wong N.
    Cancer Lett; 2007 Jun 08; 250(2):284-91. PubMed ID: 17126992
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.